One of the more complex ways that brand drug companies can hinder competition is by taking advantage of the patent process. Instances of brand company “evergreening,” making minor changes to a product and pursuing a new patent with its requisite protection from competition are commonplace. When this results in more revenue for the protected brand products, patients lose out.
![](/sites/default/files/styles/hero/public/2017-08/Pharmacist%20with%20Seniors.png?h=9d8a5886&itok=op5y2z_9)
![](/sites/default/files/styles/hero_tablet/public/2017-08/Pharmacist%20with%20Seniors.png?h=9d8a5886&itok=bxH0nQvJ)
![](/sites/default/files/styles/hero_mobile/public/2017-08/Pharmacist%20with%20Seniors.png?h=9d8a5886&itok=83Vwf-AM)